Stockreport

Sorrento Therapeutics Announces Interim Results In Osteoarthritis Knee Pain Phase 1b Trial of Resiniferatoxin With Positive Therapeutic Signal and Absence of Dose Limiting Toxicities; Pivo...

Sorrento Therapeutics, Inc.  (SRNE) 
Last sorrento therapeutics, inc. earnings: 8/9 04:49 pm Check Earnings Report
US:NASDAQ Investor Relations: sorrentotherapeutics.com/investors
PDF SAN DIEGO, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced that the phase 1b study of its non-opioid, afferent nerve [Read more]